title: Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice.
abstract: Dietary therapy has been used to treat many individuals with epilepsy whose seizures are refractory to antiepileptic drugs. The mechanisms for how dietary therapy confers seizure protection are currently not well understood. We evaluated the acute effects of glucose and β-hydroxybutyrate (the major circulating ketone body) in conferring seizure protection to the EL mouse, a model of multifactorial idiopathic generalized epilepsy. EL mice were fed either an unrestricted standard diet or a calorie-restricted standard diet to achieve a body weight reduction of 20-23%. D-Glucose, 2-deoxy-D-glucose, and β-hydroxybutyrate were supplemented in the drinking water of calorie-restricted mice for 2.5 h prior to seizure testing to simulate the effect of increased glucose availability, decreased glucose utilization, and increased ketone availability, respectively. Seizure susceptibility, body weight, plasma glucose, and β-hydroxybutyrate were measured over a nine-week treatment period. Additionally, excitatory and inhibitory amino acids were measured in the brains of mice using (1)H NMR. Glutamate decarboxylase activity was also measured to evaluate the connection between dietary therapy and brain metabolism. We found that lowering of glucose utilization is necessary to confer seizure protection with long-term (>4 weeks) calorie restriction, whereas increased ketone availability did not affect seizure susceptibility. In the absence of long-term calorie restriction, however, reduced glucose utilization and increased ketone availability did not affect seizure susceptibility. Brain excitatory and inhibitory amino acid content did not change with treatment, and glutamate decarboxylase activity was not associated with seizure susceptibility. We demonstrated that reduced glucose utilization is necessary to confer seizure protection under long-term calorie restriction in EL mice, while acute ketone supplementation did not confer seizure protection. Further studies are needed to uncover the mechanisms by which glucose utilization influences seizure susceptibility.
authors.affiliation: Biology Department, Boston College, Chestnut Hill, MA 02467, USA. Electronic address: meidenba@bc.edu.
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Meidenbauer
authors.affiliation: Chemistry Department, Boston College, Chestnut Hill, MA 02467, USA.
authors.forename: Mary F
authors.initials: MF
authors.lastname: Roberts
mesh_terms: D020155:3-Hydroxybutyric Acid / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism*; D031204:Caloric Restriction; D055423:Diet, Ketogenic; D004195:Disease Models, Animal; D004827:Epilepsy / Q000178:diet therapy*; D005260:Female; D005947:Glucose / Q000378:metabolism*; D051379:Mice; D012640:Seizures / Q000178:diet therapy / Q000517:prevention & control
chemical_list: D005947:Glucose; D020155:3-Hydroxybutyric Acid
keywords: 2-Deoxy-d-glucose (2-DG); Calorie restriction; Epilepsy; Ketogenic diet; Ketone bodies